← Back to Search

Other

Cohort 1 for Healthy Subjects

Phase 1

Waitlist Available

Research Sponsored by Sirnaomics

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 60 days

Awards & highlights

Study Summary

This trial is testing whether a new drug is safe and tolerated when given to healthy subjects.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 60 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~60 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Evaluate safety & tolerability of STP707 when administered by IV in healthy subjects

Secondary outcome measures

Evaluate (PK) of STP707 when administered by IV in healthy subjects

Trial Design

4Treatment groups

Experimental Treatment

Group I: Cohort 4Experimental Treatment1 Intervention

Dose 24mg of STP707 (8 subjects) + placebo (2 subjects) randomized

Group II: Cohort 3Experimental Treatment1 Intervention

Dose 12mg of STP707 (8 subjects) + placebo (2 subjects) randomized

Group III: Cohort 2Experimental Treatment1 Intervention

Dose 6mg of STP707 (8 subjects) + placebo (2 subjects) randomized

Group IV: Cohort 1Experimental Treatment1 Intervention

Dose 3mg of STP707 (8 subjects) + placebo (2 subjects) randomized

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

STP707

2022

Completed Phase 1

~20

Do I qualify?Apply below to find out

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Medpace, Inc.Industry Sponsor

94 Previous Clinical Trials

29,595 Total Patients Enrolled

SirnaomicsLead Sponsor

11 Previous Clinical Trials

317 Total Patients Enrolled

Francois Lebel, MDStudy DirectorChief Medical Officer

5 Previous Clinical Trials

92 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial open to elderly individuals aged 85 and above?

"The eligibility requirements for this trial stipulate that participants between 18 and 55 are qualified to enroll. For those under the age of 18, there are 50 studies available; conversely, 372 clinical trials exist for persons older than 65."

Answered by AI

What is the maximum capacity for participants in this experiment?

"Affirmative, the analysis found on clinicaltrials.gov indicates that this trial is presently recruiting patients. The project was first released February 28th 2022 and its most recent update occurred March 24th 2022; furthermore, the research requires 50 participants at a single facility."

Answered by AI

Has this treatment undergone regulatory approval by the FDA?

"Given the fact that this is a Phase 1 trial, with limited evidence backing its safety and efficacy, we have assigned it a rating of 1 on our scale."

Answered by AI

Are there still opportunities to participate in this clinical experiment?

"Affirmative. As per the information on clinicaltrials.gov, this medical trial is still accepting participants; the listing was initiated on February 28th 2022 and last updated 24th March 2022. This study seeks to enrol 50 individuals across a single site."

Answered by AI

Is it possible for me to partake in this research trial?

"In order to be considered for this study, applicants must meet the criteria of healthy subjects (hs) and occupy an age range between 18-55 years. The research team is aiming to recruit around 50 participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Study of STP707 Administered by IV in Healthy Subjects

2022. "A Study of STP707 Administered by IV in Healthy Subjects". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05309915.